Pleural mesothelioma classification update

The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes—epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and over...

Full description

Saved in:
Bibliographic Details
Published inVirchows Archiv : an international journal of pathology Vol. 478; no. 1; pp. 59 - 72
Main Authors Beasley, Mary Beth, Galateau-Salle, Francoise, Dacic, Sanja
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.01.2021
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes—epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A /MTAP improves the diagnostic sensitivity of effusion specimens and are valuable in establishing the diagnosis of epithelioid mesothelioma. The major change in the forthcoming WHO classification is the inclusion of mesothelioma in situ as a diagnostic category. In this review, we discuss recently proposed changes in the histologic classification of pleural mesothelioma, differential diagnosis, and importance of ancillary diagnostic studies.
AbstractList The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes-epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A/MTAP improves the diagnostic sensitivity of effusion specimens and are valuable in establishing the diagnosis of epithelioid mesothelioma. The major change in the forthcoming WHO classification is the inclusion of mesothelioma in situ as a diagnostic category. In this review, we discuss recently proposed changes in the histologic classification of pleural mesothelioma, differential diagnosis, and importance of ancillary diagnostic studies.
The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes—epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A /MTAP improves the diagnostic sensitivity of effusion specimens and are valuable in establishing the diagnosis of epithelioid mesothelioma. The major change in the forthcoming WHO classification is the inclusion of mesothelioma in situ as a diagnostic category. In this review, we discuss recently proposed changes in the histologic classification of pleural mesothelioma, differential diagnosis, and importance of ancillary diagnostic studies.
The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes-epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A/MTAP improves the diagnostic sensitivity of effusion specimens and are valuable in establishing the diagnosis of epithelioid mesothelioma. The major change in the forthcoming WHO classification is the inclusion of mesothelioma in situ as a diagnostic category. In this review, we discuss recently proposed changes in the histologic classification of pleural mesothelioma, differential diagnosis, and importance of ancillary diagnostic studies.The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes-epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A/MTAP improves the diagnostic sensitivity of effusion specimens and are valuable in establishing the diagnosis of epithelioid mesothelioma. The major change in the forthcoming WHO classification is the inclusion of mesothelioma in situ as a diagnostic category. In this review, we discuss recently proposed changes in the histologic classification of pleural mesothelioma, differential diagnosis, and importance of ancillary diagnostic studies.
Author Beasley, Mary Beth
Dacic, Sanja
Galateau-Salle, Francoise
Author_xml – sequence: 1
  givenname: Mary Beth
  surname: Beasley
  fullname: Beasley, Mary Beth
  organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai
– sequence: 2
  givenname: Francoise
  surname: Galateau-Salle
  fullname: Galateau-Salle, Francoise
  organization: Centre National Référent MESOPATH, Centre Leon Berard
– sequence: 3
  givenname: Sanja
  surname: Dacic
  fullname: Dacic, Sanja
  email: dacics@upmc.edu
  organization: Department of Pathology, University of Pittsburgh Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33475835$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtKAzEUQINU7EN_wIUU3IgwevOaZJZSfEFBF7oO6UyiKZmZmsws_HtjpyJ00dXdnHO590zRqGkbg9A5hhsMIG4jACMyA4IzoEBxJo7QBDNKMkJBjNAECsaznGIxRtMY15BIifMTNKaUCS4pn6DrV2_6oP28NrHtPo13ba3npdcxOutK3bm2mfebSnfmFB1b7aM5280Zen-4f1s8ZcuXx-fF3TIrqeBdVhFZSWsqzoAbTkta6cJiIawsLbBVgaXICaGUS7vSmLMigVAYWxFuhJQrOkNXw95NaL96EztVu1ga73Vj2j4qwkQhMAgGCb3cQ9dtH5p0nSIccJ6DhCJRFzuqX9WmUpvgah2-1V-FBMgBKEMbYzBWla7bvt4F7bzCoH6DqyG4ShnVNrgSSSV76t_2gxIdpJjg5sOE_7MPWD-VbY_C
CitedBy_id crossref_primary_10_36416_1806_3756_e20230343
crossref_primary_10_3892_ol_2022_13560
crossref_primary_10_15406_jlprr_2023_10_00299
crossref_primary_10_1016_j_critrevonc_2022_103821
crossref_primary_10_1016_j_prp_2024_155350
crossref_primary_10_1111_cyt_13055
crossref_primary_10_1007_s12094_024_03834_5
crossref_primary_10_1016_j_prp_2024_155276
crossref_primary_10_1186_s12929_024_00997_9
crossref_primary_10_3390_cancers17030481
crossref_primary_10_3390_ijms222212216
crossref_primary_10_1177_10668969221129888
crossref_primary_10_3390_diagnostics12122905
crossref_primary_10_1016_j_med_2022_11_004
crossref_primary_10_3390_cancers16193299
crossref_primary_10_1111_1759_7714_14827
crossref_primary_10_5507_bp_2023_008
crossref_primary_10_1007_s00428_024_03845_1
crossref_primary_10_1016_j_canlet_2023_216395
crossref_primary_10_3390_muscles3010006
crossref_primary_10_3390_jcm10112434
crossref_primary_10_1007_s00262_024_03815_1
crossref_primary_10_3390_diagnostics12020371
crossref_primary_10_1097_PAS_0000000000002297
crossref_primary_10_3389_fimmu_2023_1333661
crossref_primary_10_1016_j_lungcan_2021_10_019
crossref_primary_10_36416_1806_3756_e20210129
crossref_primary_10_1148_rg_220128
crossref_primary_10_1093_jamia_ocad132
crossref_primary_10_1038_s41598_025_92542_3
crossref_primary_10_1097_PAS_0000000000001878
crossref_primary_10_1136_jcp_2024_209592
crossref_primary_10_1111_cyt_13045
crossref_primary_10_1038_s41379_021_00895_7
crossref_primary_10_1097_CEJ_0000000000000883
crossref_primary_10_3390_cancers15205003
crossref_primary_10_1136_jclinpath_2022_208248
crossref_primary_10_3390_cancers15235534
crossref_primary_10_3390_ijms23041975
crossref_primary_10_3390_jcm13195837
crossref_primary_10_3390_cancers15123261
crossref_primary_10_3390_diagnostics12030750
crossref_primary_10_1186_s13046_022_02582_0
crossref_primary_10_3390_cancers13092278
crossref_primary_10_4081_monaldi_2024_2629
crossref_primary_10_1038_s41598_024_55083_9
crossref_primary_10_1016_j_jtcvs_2022_01_054
crossref_primary_10_3390_diagnostics12123009
Cites_doi 10.1016/j.humpath.2014.03.006
10.1097/PAS.0000000000000825
10.1043/1543-2165(2006)130[823:EORCCM]2.0.CO;2
10.1097/PAS.0000000000000394
10.1097/PAS.0000000000001416
10.1007/s00428-019-02674-x
10.1038/modpathol.2017.170
10.1097/PAS.0b013e31822a2481
10.1111/j.1440-1827.2009.02459.x
10.1016/j.jtho.2020.01.025
10.1016/j.humpath.2015.06.024
10.1016/S0140-6736(03)13079-6
10.5858/arpa.2018-0457-OA
10.1002/cncy.21928
10.1111/his.13468
10.1038/modpathol.2011.146
10.1002/dc.22852
10.1038/s41379-019-0320-y
10.1002/dc.23491
10.1309/7ECY-KN61-PP1M-52EB
10.1038/modpathol.2012.105
10.1159/000443483
10.1200/JCO.2017.76.6394
10.1038/modpathol.2015.87
10.1016/j.humpath.2018.11.005
10.1093/ajcp/110.3.397
10.5858/arpa.2017-0124-RA
10.1097/00000478-200009000-00001
10.1097/PAP.0000000000000180
10.1097/JTO.0b013e318211127a
10.1136/jclinpath-2016-203993
10.1016/j.lungcan.2016.12.017
10.1016/j.jtho.2016.06.020
10.5858/arpa.2017-0537-RA
10.1038/modpathol.2008.45
10.1038/modpathol.2017.61
10.1097/PAS.0000000000001262
10.1002/cncy.22221
10.1002/dc.23837
10.1016/j.pathol.2017.11.092
10.18632/oncotarget.27145
10.1097/PAS.0000000000000935
10.1097/PAS.0000000000000529
10.1038/s41379-019-0347-0
10.1111/his.14105
10.1038/modpathol.3800543
10.1097/PAS.0000000000001216
10.1097/PAS.0b013e3182a0218f
10.1038/modpathol.2012.39
10.1002/cncy.22326
10.1016/j.jss.2015.01.043
10.1016/j.jtho.2018.04.023
10.7150/jca.1.120
10.1016/j.jtho.2018.07.002
10.1111/j.1600-0560.2009.01379.x
10.5858/arpa.2018-0273-OA
10.5858/arpa.2012-0112-RA
10.5858/arpa.2013-0381-RA
10.1038/modpathol.2015.65
10.1016/j.humpath.2018.05.012
10.1111/pin.12623
10.1097/PAS.0b013e31802baad7
10.1002/pbc.20762
10.1016/j.lungcan.2018.09.019
10.1016/j.jtho.2019.10.023
10.1097/PAS.0000000000000976
10.1016/j.jtho.2019.08.2506
10.1016/j.jtho.2015.11.005
10.1016/j.lungcan.2014.08.017
10.1002/cncy.21269
10.3109/01913128809064207
10.5858/arpa.2017-0295-OA
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021
The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021
– notice: The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7T5
7T7
7TM
7TO
7U7
7U9
7X7
7XB
88A
88E
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
DOI 10.1007/s00428-021-03031-7
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
Toxicology Abstracts
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Central Student

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-2307
EndPage 72
ExternalDocumentID 33475835
10_1007_s00428_021_03031_7
Genre Journal Article
Review
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
1N0
2.D
203
28-
29Q
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
78A
7RV
7X7
88A
88E
8AO
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEUYN
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIHBH
EIOEI
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LK8
LLZTM
M0L
M1P
M4Y
M7P
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
RNS
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7M
YLTOR
Z45
Z7U
Z81
Z82
Z87
Z8O
Z8U
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7T7
7TM
7TO
7U7
7U9
7XB
8FD
8FK
ABRTQ
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
7X8
ID FETCH-LOGICAL-c375t-d28d8fed5405e53c3da9f177f8cf04b91876223358fba154954009efd25e788b3
IEDL.DBID U2A
ISSN 0945-6317
1432-2307
IngestDate Fri Jul 11 02:17:57 EDT 2025
Sat Aug 23 12:50:23 EDT 2025
Thu Apr 03 06:56:36 EDT 2025
Thu Apr 24 22:59:24 EDT 2025
Tue Jul 01 02:59:55 EDT 2025
Fri Feb 21 02:48:14 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Histologic classification
Mesothelioma
Pleura
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-d28d8fed5405e53c3da9f177f8cf04b91876223358fba154954009efd25e788b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
PMID 33475835
PQID 2501660809
PQPubID 54092
PageCount 14
ParticipantIDs proquest_miscellaneous_2479710740
proquest_journals_2501660809
pubmed_primary_33475835
crossref_citationtrail_10_1007_s00428_021_03031_7
crossref_primary_10_1007_s00428_021_03031_7
springer_journals_10_1007_s00428_021_03031_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210100
2021-01-00
2021-Jan
20210101
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 1
  year: 2021
  text: 20210100
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationSubtitle European Journal of Pathology
PublicationTitle Virchows Archiv : an international journal of pathology
PublicationTitleAbbrev Virchows Arch
PublicationTitleAlternate Virchows Arch
PublicationYear 2021
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Davidson, Totsch, Wohlschlaeger, Hager, Pinamonti (CR25) 2018; 79
Le Stang, Burke, Blaizot, Gibbs, Lebailly, Clin, Girard, Galateau-Salle (CR47) 2020; 144
Tozbikian, Zynger (CR71) 2019; 85
Zhang, Brambilla, Molyneaux, Rice, Robertus, Jordan, Lim, Lang-Lazdunski, Begum, Dusmet, Anikin, Beddow, Finch, Asadi, Popat, Cookson, Moffatt, Nicholson (CR75) 2020; 44
Churg, Galateau-Salle (CR18) 2012; 136
Ahadi, Gill (CR1) 2019; 43
Walts, Hiroshima, McGregor, Wu, Husain, Marchevsky (CR72) 2016; 44
Matsumoto, Nabeshima, Kamei, Hiroshima, Kawahara, Hata, Marukawa, Matsuno, Taguchi, Tsujimura (CR50) 2013; 121
Churg, Hwang, Tan, Qing, Taher, Tong, Bilawich, Dacic (CR20) 2018; 72
Rosen, Karrison, Ananthanarayanan, Gallan, Adusumilli, Alchami, Attanoos, Brcic, Butnor, Galateau-Salle, Hiroshima, Kadota, Klampatsa, Stang, Lindenmann, Litzky, Marchevsky, Medeiros, Montero, Moore, Nabeshima, Pavlisko, Roggli, Sauter, Sharma, Sheaff, Travis, Vigneswaran, Vrugt, Walts, Tjota, Krausz, Husain (CR67) 2018; 31
Cigognetti, Lonardi, Fisogni, Balzarini, Pellegrini, Tironi, Bercich, Bugatti, Rossi, Murer, Barbareschi, Giuliani, Cavazza, Marchetti, Vermi, Facchetti (CR22) 2015; 28
Sauter, Graham, Larsen, Jenkins, Roden, Boland (CR68) 2017; 30
Miettinen, McCue, Sarlomo-Rikala, Rys, Czapiewski, Wazny, Langfort, Waloszczyk, Biernat, Lasota, Wang (CR54) 2014; 38
Chapel, Husain, Krausz, McGregor (CR13) 2017; 41
Cozzi, Oprescu, Rullo, Ascoli (CR23) 2018; 46
Mogi, Nabeshima, Hamasaki, Uesugi, Tamura, Iwasaki, Shirakusa, Iwasaki (CR56) 2009; 59
Ordonez (CR59) 2006; 19
Sheffield, Hwang, Lee, Thompson, Rodriguez, Tse, Gown, Churg (CR69) 2015; 39
Whitaker, Henderson, Shilkin (CR73) 1992; 9
Righi, Duregon, Vatrano, Izzo, Giorcelli, Rondon-Lagos, Ascoli, Ruffini, Ventura, Volante, Papotti, Scagliotti (CR66) 2016; 11
Ordonez, Sahin (CR62) 2014; 45
Hwang, Sheffield, Rodriguez, Thompson, Tse, Gown, Churg (CR36) 2016; 40
Knoepp, Placido, Fields, Thomas, Roh (CR45) 2013; 41
Henderson, Attwood, Constance, Shilkin, Steele (CR32) 1988; 12
Kinoshita, Hida, Hamasaki, Matsumoto, Sato, Tsujimura, Kawahara, Hiroshima, Oda, Nabeshima (CR44) 2018; 126
Pelosi, Papotti, Righi, Rossi, Ferrero, Bosari, Calabrese, Kern, Maisonneuve, Sonzogni, Albini, Harari, Barbieri, Capelletto, Catino, Cavone, De Palma, Fusco, Lunardi, Maiorano, Marzullo, Novello, Papanikolaou, Pasello, Pennella, Pezzuto, Punzi, Prisciandaro, Rea, Rosso, Scattone, Serio (CR63) 2018; 13
Attanoos, Pugh (CR5) 2018; 142
(CR29) 2016; 11
Churg, Galateau-Salle, Roden, Attanoos, von der Thusen, Tsao, Chang, De Perrot, Dacic (CR21) 2020; 33
Galateau-Salle, Attanoos, Gibbs, Burke, Astoul, Rolland, Ilg, Pairon, Brochard, Begueret, Vignaud, Kerr, Launoy, Imbernon, Goldberg (CR30) 2007; 31
Garrido-Ruiz, Rodriguez-Pinilla, Perez-Gomez, Rodriguez-Peralto (CR31) 2010; 37
Kinoshita, Hamasaki, Yoshimura, Matsumoto, Sato, Tsujimura, Ueda, Makihata, Kato, Iwasaki, Nabeshima (CR43) 2018; 125
Pillappa, Maleszewski, Sukov, Bedroske, Greipp, Boland, Yi, Peikert, Aubry, Roden (CR64) 2018; 42
Galateau Salle, Le Stang, Nicholson, Pissaloux, Churg, Klebe, Roggli, Tazelaar, Vignaud, Attanoos, Beasley, Begueret, Capron, Chirieac, Copin, Dacic, Danel, Foulet-Roge, Gibbs, Giusiano-Courcambeck, Hiroshima, Hofman, Husain, Kerr, Marchevsky, Nabeshima, Picquenot, Rouquette, Sagan, Sauter, Thivolet, Travis, Tsao, Weynand, Damiola, Scherpereel, Pairon, Lantuejoul, Rusch, Girard (CR27) 2018; 13
Fea, Travis, Burke, Marx, Nicholson (CR26) 2015
Butnor, Nicholson, Allred, Zander, Henderson, Barrios, Haque, Allen, Killen, Cagle (CR12) 2006; 130
Chevrier, Monaco, Jerome, Galateau-Salle, Churg, Dacic (CR14) 2020; 128
Galateau Salle, Le Stang, Tirode, Courtiol, Nicholson, Tsao, Tazelaar, Churg, Dacic, Roggli, Pissaloux, Maussion, Moarii, Beasley, Begueret, Chapel, Copin, Gibbs, Klebe, Lantuejoul, Nabeshima, Vignaud, Attanoos, Brcic, Capron, Chirieac, Damiola, Sequeiros, Cazes, Damotte, Foulet, Giusiano-Courcambeck, Hiroshima, Hofman, Husain, Kerr, Marchevsky, Paindavoine, Picquenot, Rouquette, Sagan, Sauter, Thivolet, Brevet, Rouvier, Travis, Planchard, Weynand, Clozel, Wainrib, Fernandez-Cuesta, Pairon, Rusch, Girard (CR28) 2020; 15
Andrici, Sheen, Sioson, Wardell, Clarkson, Watson, Ahadi, Farzin, Toon, Gill (CR3) 2015; 28
Khalidi, Medeiros, Battifora (CR40) 2000; 113
(CR17) 2011; 35
Husain, Colby, Ordonez, Allen, Attanoos, Beasley, Butnor, Chirieac, Churg, Dacic, Galateau-Salle, Gibbs, Gown, Krausz, Litzky, Marchevsky, Nicholson, Roggli, Sharma, Travis, Walts, Wick (CR35) 2018; 142
Kadota, Suzuki, Colovos, Sima, Rusch, Travis, Adusumilli (CR38) 2012; 25
Brcic, Vlacic, Quehenberger, Kern (CR11) 2018; 142
Maskell, Gleeson, Davies (CR49) 2003; 361
Hida, Hamasaki, Matsumoto, Sato, Tsujimura, Kawahara, Iwasaki, Okamoto, Oda, Honda, Nabeshima (CR34) 2017; 104
Minami, Jimbo, Tanaka, Hokka, Miyamoto, Itoh, Maniwa (CR55) 2020; 476
Karavitakis, Moschovi, Stefanaki, Karamolegou, Dimitriadis, Pandis, Karakousis, Tzortzatou-Stathopoulou (CR39) 2007; 49
Berg, Dacic, Miller, Cheung, Churg (CR7) 2018; 142
Kindler, Ismaila, Armato, Bueno, Hesdorffer, Jahan, Jones, Miettinen, Pass, Rimner, Rusch, Sterman, Thomas, Hassan (CR42) 2018; 36
Ordonez (CR60) 2012; 25
Berg, Churg, Cheung, Dacic (CR8) 2020; 128
Bonk, Kluth, Hube-Magg, Polonski, Soekeland, Makropidi-Fraune, Moller-Koop, Witt, Luebke, Hinsch, Burandt, Steurer, Clauditz, Schlomm, Perez, Graefen, Heinzer, Huland, Izbicki, Wilczak, Minner, Sauter, Simon (CR10) 2019; 10
Kimura, Hasegawa, Hiroshima (CR41) 2018; 68
Churg, Colby, Cagle, Corson, Gibbs, Gilks, Grimes, Hammar, Roggli, Travis (CR19) 2000; 24
Monaco, Mehrad, Dacic (CR57) 2018; 25
Mansfield, Symanowski, Peikert (CR48) 2014; 86
Nicholson, Sauter, Nowak, Kindler, Gill, Remy-Jardin, Armato, Fernandez-Cuesta, Bueno, Alcala, Foll, Pass, Attanoos, Baas, Beasley, Brcic, Butnor, Chirieac, Churg, Courtiol, Dacic, De Perrot, Frauenfelder, Gibbs, Hirsch, Hiroshima, Husain, Klebe, Lantuejoul, Moreira, Opitz, Perol, Roden, Roggli, Scherpereel, Tirode, Tazelaar, Travis, Tsao, van Schil, Vignaud, Weynand, Lang-Lazdunski, Cree, Rusch, Girard, Galateau-Salle (CR58) 2020; 15
Berg, Churg (CR6) 2017; 41
Alchami, Attanoos, Bamber (CR2) 2017; 70
Bilecz, Stockhammer, Theegarten, Kern, Jakopovic, Samarzija, Klikovits, Hoda, Dome, Oberndorfer, Muellauer, Fillinger, Kovacs, Pirker, Schuler, Plones, Aigner, Klepetko, Berger, Brcic, Laszlo, Hegedus (CR9) 2020; 77
McGregor, Dunning, Hyjek, Vigneswaran, Husain, Krausz (CR51) 2015; 46
Chung, Man, Lupton (CR16) 2010; 1
Henderson, Shilkin, Whitaker (CR33) 1998; 110
Laurent, Begueret, Bonhomme, Veillon, Thumerel, Velasco, Brouste, Hoppe, Fournier, Grellety, MacGrogan (CR46) 2019; 43
Dacic, Le Stang, Husain, Weynand, Beasley, Butnor, Chapel, Gibbs, Klebe, Lantuejoul, Roden, Roggli, Tazelaar, Vignaud, Galateau-Salle (CR24) 2020; 33
Arif, Husain (CR4) 2015; 139
Rekhtman, Montecalvo, Chang, Alex, Ptashkin, Ai, Sauter, Kezlarian, Jungbluth, Desmeules, Beras, Bishop, Plodkowski, Gounder, Schoenfeld, Namakydoust, Li, Rudin, Riely, Jones, Ladanyi, Travis (CR65) 2020; 15
Ordonez (CR61) 2012; 25
Meyerhoff, Yang, Speicher, Gulack, Hartwig, D’Amico, Harpole, Berry (CR53) 2015; 196
Metintas, Yildirim, Kaya, Ak, Dundar, Ozkan, Metintas (CR52) 2016; 91
Sterrett, Whitaker, Shilkin, Walters (CR70) 1987; 31
Chiosea, Krasinskas, Cagle, Mitchell, Zander, Dacic (CR15) 2008; 21
Kadota, Suzuki, Sima, Rusch, Adusumilli, Travis (CR37) 2011; 6
Wilkinson, Coucher, Murphy, Joubert, Cooper (CR74) 2018; 50
FS Alchami (3031_CR2) 2017; 70
A Churg (3031_CR21) 2020; 33
T Hida (3031_CR34) 2017; 104
RL Attanoos (3031_CR5) 2018; 142
M Chevrier (3031_CR14) 2020; 128
K Minami (3031_CR55) 2020; 476
MS Ahadi (3031_CR1) 2019; 43
Q Arif (3031_CR4) 2015; 139
F Galateau Salle (3031_CR27) 2018; 13
Y Kinoshita (3031_CR44) 2018; 126
KB Berg (3031_CR6) 2017; 41
L Righi (3031_CR66) 2016; 11
S Bonk (3031_CR10) 2019; 10
A Bilecz (3031_CR9) 2020; 77
Churg A, Cagle P, Colby TV, Corson JM, Gibbs AR, Hammar S, Ordonez N, Roggli VL, Tazelaar HD, Travis WD, Wick M, Panel US-CMR (3031_CR17) 2011; 35
G-S Fea (3031_CR26) 2015
DW Henderson (3031_CR33) 1998; 110
N Le Stang (3031_CR47) 2020; 144
A Mogi (3031_CR56) 2009; 59
KJ Butnor (3031_CR12) 2006; 130
NA Maskell (3031_CR49) 2003; 361
GF Sterrett (3031_CR70) 1987; 31
YZ Zhang (3031_CR75) 2020; 44
EM Karavitakis (3031_CR39) 2007; 49
E Laurent (3031_CR46) 2019; 43
RR Meyerhoff (3031_CR53) 2015; 196
AE Walts (3031_CR72) 2016; 44
M Cigognetti (3031_CR22) 2015; 28
DW Henderson (3031_CR32) 1988; 12
M Miettinen (3031_CR54) 2014; 38
GH Tozbikian (3031_CR71) 2019; 85
D Whitaker (3031_CR73) 1992; 9
NG Ordonez (3031_CR59) 2006; 19
KB Berg (3031_CR8) 2020; 128
A Churg (3031_CR18) 2012; 136
R Pillappa (3031_CR64) 2018; 42
N Rekhtman (3031_CR65) 2020; 15
L Brcic (3031_CR11) 2018; 142
LS Chung (3031_CR16) 2010; 1
Galateau-Salle F, Churg A, Roggli V, Travis WD, World Health Organization Committee for Tumors of the P (3031_CR29) 2016; 11
SM Knoepp (3031_CR45) 2013; 41
NG Ordonez (3031_CR62) 2014; 45
G Pelosi (3031_CR63) 2018; 13
NG Ordonez (3031_CR61) 2012; 25
K Kadota (3031_CR37) 2011; 6
F Galateau-Salle (3031_CR30) 2007; 31
F Galateau Salle (3031_CR28) 2020; 15
HL Kindler (3031_CR42) 2018; 36
N Kimura (3031_CR41) 2018; 68
M Metintas (3031_CR52) 2016; 91
A Churg (3031_CR19) 2000; 24
AN Husain (3031_CR35) 2018; 142
A Churg (3031_CR20) 2018; 72
SM McGregor (3031_CR51) 2015; 46
NG Ordonez (3031_CR60) 2012; 25
DB Chapel (3031_CR13) 2017; 41
LE Rosen (3031_CR67) 2018; 31
JL Sauter (3031_CR68) 2017; 30
S Matsumoto (3031_CR50) 2013; 121
K Kadota (3031_CR38) 2012; 25
I Cozzi (3031_CR23) 2018; 46
AS Mansfield (3031_CR48) 2014; 86
AG Nicholson (3031_CR58) 2020; 15
KB Berg (3031_CR7) 2018; 142
S Chiosea (3031_CR15) 2008; 21
HS Khalidi (3031_CR40) 2000; 113
HC Hwang (3031_CR36) 2016; 40
J Andrici (3031_CR3) 2015; 28
B Davidson (3031_CR25) 2018; 79
Y Kinoshita (3031_CR43) 2018; 125
L Wilkinson (3031_CR74) 2018; 50
BS Sheffield (3031_CR69) 2015; 39
MC Garrido-Ruiz (3031_CR31) 2010; 37
S Dacic (3031_CR24) 2020; 33
S Monaco (3031_CR57) 2018; 25
References_xml – volume: 45
  start-page: 1529
  year: 2014
  end-page: 1540
  ident: CR62
  article-title: Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2014.03.006
– volume: 41
  start-page: 1221
  year: 2017
  end-page: 1225
  ident: CR6
  article-title: GATA3 Immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000825
– volume: 130
  start-page: 823
  year: 2006
  end-page: 827
  ident: CR12
  article-title: Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma
  publication-title: Arch Pathol Lab Med
  doi: 10.1043/1543-2165(2006)130[823:EORCCM]2.0.CO;2
– volume: 39
  start-page: 977
  year: 2015
  end-page: 982
  ident: CR69
  article-title: BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000394
– volume: 44
  start-page: 347
  year: 2020
  end-page: 356
  ident: CR75
  article-title: Utility of nuclear grading system in epithelioid malignant pleural mesothelioma in biopsy-heavy setting: an external validation study of 563 cases
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001416
– volume: 476
  start-page: 469
  year: 2020
  end-page: 473
  ident: CR55
  article-title: Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report
  publication-title: Virchows Arch
  doi: 10.1007/s00428-019-02674-x
– volume: 31
  start-page: 598
  year: 2018
  end-page: 606
  ident: CR67
  article-title: Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2017.170
– volume: 35
  start-page: 1823
  year: 2011
  end-page: 1829
  ident: CR17
  article-title: The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31822a2481
– volume: 59
  start-page: 874
  year: 2009
  end-page: 879
  ident: CR56
  article-title: Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis
  publication-title: Pathol Int
  doi: 10.1111/j.1440-1827.2009.02459.x
– volume: 15
  start-page: 1037
  year: 2020
  end-page: 1053
  ident: CR28
  article-title: Comprehensive molecular and pathologic evaluation of transitional mesothelioma assisted by deep learning approach: a multi-institutional study of the international mesothelioma panel from the MESOPATH reference center
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2020.01.025
– volume: 46
  start-page: 1670
  year: 2015
  end-page: 1678
  ident: CR51
  article-title: BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2015.06.024
– volume: 31
  start-page: 185
  year: 1987
  end-page: 193
  ident: CR70
  article-title: Fine needle aspiration cytology of malignant mesothelioma
  publication-title: Acta Cytol
– volume: 361
  start-page: 1326
  year: 2003
  end-page: 1330
  ident: CR49
  article-title: Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)13079-6
– volume: 144
  start-page: 446
  year: 2020
  end-page: 456
  ident: CR47
  article-title: Differential diagnosis of epithelioid malignant mesothelioma with lung and breast pleural metastasis: a systematic review compared with a standardized panel of antibodies-a new proposal that may influence pathologic practice
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2018-0457-OA
– volume: 126
  start-page: 54
  year: 2018
  end-page: 63
  ident: CR44
  article-title: A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.21928
– volume: 72
  start-page: 1033
  year: 2018
  end-page: 1038
  ident: CR20
  article-title: Malignant mesothelioma in situ
  publication-title: Histopathology
  doi: 10.1111/his.13468
– volume: 25
  start-page: 260
  year: 2012
  end-page: 271
  ident: CR38
  article-title: A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2011.146
– volume: 41
  start-page: 425
  year: 2013
  end-page: 430
  ident: CR45
  article-title: The application of immunocytochemistry to direct smears in the diagnosis of effusions
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.22852
– start-page: 128
  year: 2015
  end-page: 135
  ident: CR26
  article-title: Tumors of the pleura
  publication-title: WHO Classification of tumors of the lung, pleura, thymus and heart
– volume: 33
  start-page: 255
  year: 2020
  end-page: 262
  ident: CR24
  article-title: Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas
  publication-title: Mod Pathol
  doi: 10.1038/s41379-019-0320-y
– volume: 44
  start-page: 599
  year: 2016
  end-page: 606
  ident: CR72
  article-title: BAP1 immunostain and CDKN2A (p16) FISH analysis: clinical applicability for the diagnosis of malignant mesothelioma in effusions
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.23491
– volume: 113
  start-page: 649
  year: 2000
  end-page: 654
  ident: CR40
  article-title: Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma
  publication-title: Am J Clin Pathol
  doi: 10.1309/7ECY-KN61-PP1M-52EB
– volume: 25
  start-page: 1481
  year: 2012
  end-page: 1495
  ident: CR60
  article-title: Deciduoid mesothelioma: report of 21 cases with review of the literature
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2012.105
– volume: 91
  start-page: 156
  year: 2016
  end-page: 163
  ident: CR52
  article-title: CT scan-guided Abrams’ needle pleural biopsy versus ultrasound-assisted cutting needle pleural biopsy for diagnosis in patients with pleural effusion: a randomized, controlled trial
  publication-title: Respiration
  doi: 10.1159/000443483
– volume: 36
  start-page: 1343
  year: 2018
  end-page: 1373
  ident: CR42
  article-title: Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.76.6394
– volume: 28
  start-page: 1360
  year: 2015
  end-page: 1368
  ident: CR3
  article-title: Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2015.87
– volume: 85
  start-page: 221
  year: 2019
  end-page: 227
  ident: CR71
  article-title: A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2018.11.005
– volume: 110
  start-page: 397
  year: 1998
  end-page: 404
  ident: CR33
  article-title: Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review
  publication-title: Am J Clin Pathol
  doi: 10.1093/ajcp/110.3.397
– volume: 142
  start-page: 89
  year: 2018
  end-page: 108
  ident: CR35
  article-title: Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2017-0124-RA
– volume: 24
  start-page: 1183
  year: 2000
  end-page: 1200
  ident: CR19
  article-title: The separation of benign and malignant mesothelial proliferations
  publication-title: Am J Surg Pathol
  doi: 10.1097/00000478-200009000-00001
– volume: 25
  start-page: 24
  year: 2018
  end-page: 30
  ident: CR57
  article-title: Recent advances in the diagnosis of malignant mesothelioma: focus on approach in challenging cases and in limited tissue and cytologic samples
  publication-title: Adv Anat Pathol
  doi: 10.1097/PAP.0000000000000180
– volume: 6
  start-page: 896
  year: 2011
  end-page: 904
  ident: CR37
  article-title: Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e318211127a
– volume: 70
  start-page: 179
  year: 2017
  end-page: 182
  ident: CR2
  article-title: Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma
  publication-title: J Clin Pathol
  doi: 10.1136/jclinpath-2016-203993
– volume: 9
  start-page: 151
  year: 1992
  end-page: 161
  ident: CR73
  article-title: The concept of mesothelioma in situ: implications for diagnosis and histogenesis
  publication-title: Semin Diagn Pathol
– volume: 104
  start-page: 98
  year: 2017
  end-page: 105
  ident: CR34
  article-title: Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2016.12.017
– volume: 11
  start-page: 2006
  year: 2016
  end-page: 2017
  ident: CR66
  article-title: BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2016.06.020
– volume: 142
  start-page: 902
  year: 2018
  end-page: 913
  ident: CR5
  article-title: The diagnosis of pleural tumors other than mesothelioma
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2017-0537-RA
– volume: 21
  start-page: 742
  year: 2008
  end-page: 747
  ident: CR15
  article-title: Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2008.45
– volume: 30
  start-page: 1422
  year: 2017
  end-page: 1432
  ident: CR68
  article-title: SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2017.61
– volume: 43
  start-page: 1154
  year: 2019
  end-page: 1155
  ident: CR1
  article-title: SMARCA4 loss is very rare in thoracic mesothelioma
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001262
– volume: 128
  start-page: 126
  year: 2020
  end-page: 132
  ident: CR8
  article-title: Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.22221
– volume: 46
  start-page: 9
  year: 2018
  end-page: 14
  ident: CR23
  article-title: Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.23837
– volume: 50
  start-page: 469
  year: 2018
  end-page: 472
  ident: CR74
  article-title: CIC-rearranged sarcoma of the pleura: an unreported primary site, expanding the anatomical distribution of an emerging entity
  publication-title: Pathology
  doi: 10.1016/j.pathol.2017.11.092
– volume: 10
  start-page: 5439
  year: 2019
  end-page: 5453
  ident: CR10
  article-title: Prognostic and diagnostic role of PSA immunohistochemistry: a tissue microarray study on 21,000 normal and cancerous tissues
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.27145
– volume: 41
  start-page: 1675
  year: 2017
  end-page: 1682
  ident: CR13
  article-title: PAX8 expression in a subset of malignant peritoneal mesotheliomas and benign mesothelium has diagnostic implications in the differential diagnosis of ovarian serous carcinoma
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000935
– volume: 40
  start-page: 120
  year: 2016
  end-page: 126
  ident: CR36
  article-title: Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000529
– volume: 33
  start-page: 297
  year: 2020
  end-page: 302
  ident: CR21
  article-title: Malignant mesothelioma in situ: morphologic features and clinical outcome
  publication-title: Mod Pathol
  doi: 10.1038/s41379-019-0347-0
– volume: 77
  start-page: 55
  year: 2020
  end-page: 66
  ident: CR9
  article-title: Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
  publication-title: Histopathology
  doi: 10.1111/his.14105
– volume: 19
  start-page: 373
  year: 2006
  end-page: 383
  ident: CR59
  article-title: Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.3800543
– volume: 43
  start-page: 293
  year: 2019
  end-page: 302
  ident: CR46
  article-title: SOX10, GATA3, GCDFP15, androgen receptor, and mammaglobin for the differential diagnosis between triple-negative breast cancer and TTF1-negative lung adenocarcinoma
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001216
– volume: 38
  start-page: 13
  year: 2014
  end-page: 22
  ident: CR54
  article-title: GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e3182a0218f
– volume: 25
  start-page: 1011
  year: 2012
  end-page: 1022
  ident: CR61
  article-title: Pleomorphic mesothelioma: report of 10 cases
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2012.39
– volume: 128
  start-page: 939
  year: 2020
  end-page: 947
  ident: CR14
  article-title: Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.22326
– volume: 196
  start-page: 23
  year: 2015
  end-page: 32
  ident: CR53
  article-title: Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2015.01.043
– volume: 13
  start-page: 1189
  year: 2018
  end-page: 1203
  ident: CR27
  article-title: New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the international mesothelioma panel from the MESOPATH reference center
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2018.04.023
– volume: 1
  start-page: 120
  year: 2010
  end-page: 125
  ident: CR16
  article-title: WT-1 expression in a spectrum of melanocytic lesions: implication for differential diagnosis
  publication-title: J Cancer
  doi: 10.7150/jca.1.120
– volume: 13
  start-page: 1750
  year: 2018
  end-page: 1761
  ident: CR63
  article-title: Pathologic grading of malignant pleural mesothelioma: an evidence-based proposal
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2018.07.002
– volume: 37
  start-page: 542
  year: 2010
  end-page: 548
  ident: CR31
  article-title: WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis
  publication-title: J Cutan Pathol
  doi: 10.1111/j.1600-0560.2009.01379.x
– volume: 142
  start-page: 1549
  year: 2018
  end-page: 1553
  ident: CR7
  article-title: Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2018-0273-OA
– volume: 136
  start-page: 1217
  year: 2012
  end-page: 1226
  ident: CR18
  article-title: The separation of benign and malignant mesothelial proliferations
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2012-0112-RA
– volume: 139
  start-page: 978
  year: 2015
  end-page: 980
  ident: CR4
  article-title: Malignant mesothelioma diagnosis
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2013-0381-RA
– volume: 28
  start-page: 1043
  year: 2015
  end-page: 1057
  ident: CR22
  article-title: BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2015.65
– volume: 79
  start-page: 122
  year: 2018
  end-page: 126
  ident: CR25
  article-title: The diagnostic role of BAP1 in serous effusions
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2018.05.012
– volume: 68
  start-page: 128
  year: 2018
  end-page: 132
  ident: CR41
  article-title: SMARCB1/INI1/BAF47- deficient pleural malignant mesothelioma with rhabdoid features
  publication-title: Pathol Int
  doi: 10.1111/pin.12623
– volume: 31
  start-page: 711
  year: 2007
  end-page: 716
  ident: CR30
  article-title: Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31802baad7
– volume: 49
  start-page: 335
  year: 2007
  end-page: 338
  ident: CR39
  article-title: Desmoplastic small round cell tumor of the pleura
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.20762
– volume: 125
  start-page: 198
  year: 2018
  end-page: 204
  ident: CR43
  article-title: A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2018.09.019
– volume: 15
  start-page: 231
  year: 2020
  end-page: 247
  ident: CR65
  article-title: SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2019.10.023
– volume: 42
  start-page: 256
  year: 2018
  end-page: 263
  ident: CR64
  article-title: Loss of BAP1 expression in atypical mesothelial proliferations helps to predict malignant mesothelioma
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000976
– volume: 15
  start-page: 29
  year: 2020
  end-page: 49
  ident: CR58
  article-title: EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2019.08.2506
– volume: 11
  start-page: 142
  year: 2016
  end-page: 154
  ident: CR29
  article-title: The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2015.11.005
– volume: 86
  start-page: 133
  year: 2014
  end-page: 136
  ident: CR48
  article-title: Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2014.08.017
– volume: 121
  start-page: 415
  year: 2013
  end-page: 422
  ident: CR50
  article-title: Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.21269
– volume: 12
  start-page: 367
  year: 1988
  end-page: 384
  ident: CR32
  article-title: Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma
  publication-title: Ultrastruct Pathol
  doi: 10.3109/01913128809064207
– volume: 142
  start-page: 747
  year: 2018
  end-page: 752
  ident: CR11
  article-title: Reproducibility of malignant pleural mesothelioma histopathologic subtyping
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2017-0295-OA
– volume: 142
  start-page: 902
  year: 2018
  ident: 3031_CR5
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2017-0537-RA
– volume: 113
  start-page: 649
  year: 2000
  ident: 3031_CR40
  publication-title: Am J Clin Pathol
  doi: 10.1309/7ECY-KN61-PP1M-52EB
– volume: 79
  start-page: 122
  year: 2018
  ident: 3031_CR25
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2018.05.012
– volume: 110
  start-page: 397
  year: 1998
  ident: 3031_CR33
  publication-title: Am J Clin Pathol
  doi: 10.1093/ajcp/110.3.397
– volume: 28
  start-page: 1360
  year: 2015
  ident: 3031_CR3
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2015.87
– volume: 40
  start-page: 120
  year: 2016
  ident: 3031_CR36
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000529
– volume: 50
  start-page: 469
  year: 2018
  ident: 3031_CR74
  publication-title: Pathology
  doi: 10.1016/j.pathol.2017.11.092
– volume: 44
  start-page: 599
  year: 2016
  ident: 3031_CR72
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.23491
– volume: 10
  start-page: 5439
  year: 2019
  ident: 3031_CR10
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.27145
– volume: 13
  start-page: 1750
  year: 2018
  ident: 3031_CR63
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2018.07.002
– volume: 33
  start-page: 297
  year: 2020
  ident: 3031_CR21
  publication-title: Mod Pathol
  doi: 10.1038/s41379-019-0347-0
– volume: 43
  start-page: 1154
  year: 2019
  ident: 3031_CR1
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001262
– volume: 19
  start-page: 373
  year: 2006
  ident: 3031_CR59
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.3800543
– volume: 45
  start-page: 1529
  year: 2014
  ident: 3031_CR62
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2014.03.006
– volume: 142
  start-page: 89
  year: 2018
  ident: 3031_CR35
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2017-0124-RA
– volume: 361
  start-page: 1326
  year: 2003
  ident: 3031_CR49
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)13079-6
– volume: 9
  start-page: 151
  year: 1992
  ident: 3031_CR73
  publication-title: Semin Diagn Pathol
– volume: 46
  start-page: 9
  year: 2018
  ident: 3031_CR23
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.23837
– volume: 70
  start-page: 179
  year: 2017
  ident: 3031_CR2
  publication-title: J Clin Pathol
  doi: 10.1136/jclinpath-2016-203993
– volume: 37
  start-page: 542
  year: 2010
  ident: 3031_CR31
  publication-title: J Cutan Pathol
  doi: 10.1111/j.1600-0560.2009.01379.x
– volume: 11
  start-page: 2006
  year: 2016
  ident: 3031_CR66
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2016.06.020
– volume: 139
  start-page: 978
  year: 2015
  ident: 3031_CR4
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2013-0381-RA
– volume: 6
  start-page: 896
  year: 2011
  ident: 3031_CR37
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e318211127a
– volume: 31
  start-page: 598
  year: 2018
  ident: 3031_CR67
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2017.170
– volume: 13
  start-page: 1189
  year: 2018
  ident: 3031_CR27
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2018.04.023
– volume: 44
  start-page: 347
  year: 2020
  ident: 3031_CR75
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001416
– volume: 41
  start-page: 1221
  year: 2017
  ident: 3031_CR6
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000825
– volume: 142
  start-page: 747
  year: 2018
  ident: 3031_CR11
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2017-0295-OA
– volume: 1
  start-page: 120
  year: 2010
  ident: 3031_CR16
  publication-title: J Cancer
  doi: 10.7150/jca.1.120
– volume: 25
  start-page: 1011
  year: 2012
  ident: 3031_CR61
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2012.39
– volume: 42
  start-page: 256
  year: 2018
  ident: 3031_CR64
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000976
– volume: 126
  start-page: 54
  year: 2018
  ident: 3031_CR44
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.21928
– volume: 121
  start-page: 415
  year: 2013
  ident: 3031_CR50
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.21269
– start-page: 128
  volume-title: WHO Classification of tumors of the lung, pleura, thymus and heart
  year: 2015
  ident: 3031_CR26
– volume: 31
  start-page: 711
  year: 2007
  ident: 3031_CR30
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31802baad7
– volume: 21
  start-page: 742
  year: 2008
  ident: 3031_CR15
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2008.45
– volume: 15
  start-page: 29
  year: 2020
  ident: 3031_CR58
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2019.08.2506
– volume: 91
  start-page: 156
  year: 2016
  ident: 3031_CR52
  publication-title: Respiration
  doi: 10.1159/000443483
– volume: 142
  start-page: 1549
  year: 2018
  ident: 3031_CR7
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2018-0273-OA
– volume: 72
  start-page: 1033
  year: 2018
  ident: 3031_CR20
  publication-title: Histopathology
  doi: 10.1111/his.13468
– volume: 25
  start-page: 1481
  year: 2012
  ident: 3031_CR60
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2012.105
– volume: 43
  start-page: 293
  year: 2019
  ident: 3031_CR46
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001216
– volume: 39
  start-page: 977
  year: 2015
  ident: 3031_CR69
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000394
– volume: 86
  start-page: 133
  year: 2014
  ident: 3031_CR48
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2014.08.017
– volume: 15
  start-page: 1037
  year: 2020
  ident: 3031_CR28
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2020.01.025
– volume: 15
  start-page: 231
  year: 2020
  ident: 3031_CR65
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2019.10.023
– volume: 476
  start-page: 469
  year: 2020
  ident: 3031_CR55
  publication-title: Virchows Arch
  doi: 10.1007/s00428-019-02674-x
– volume: 128
  start-page: 126
  year: 2020
  ident: 3031_CR8
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.22221
– volume: 33
  start-page: 255
  year: 2020
  ident: 3031_CR24
  publication-title: Mod Pathol
  doi: 10.1038/s41379-019-0320-y
– volume: 125
  start-page: 198
  year: 2018
  ident: 3031_CR43
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2018.09.019
– volume: 46
  start-page: 1670
  year: 2015
  ident: 3031_CR51
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2015.06.024
– volume: 24
  start-page: 1183
  year: 2000
  ident: 3031_CR19
  publication-title: Am J Surg Pathol
  doi: 10.1097/00000478-200009000-00001
– volume: 11
  start-page: 142
  year: 2016
  ident: 3031_CR29
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2015.11.005
– volume: 59
  start-page: 874
  year: 2009
  ident: 3031_CR56
  publication-title: Pathol Int
  doi: 10.1111/j.1440-1827.2009.02459.x
– volume: 49
  start-page: 335
  year: 2007
  ident: 3031_CR39
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.20762
– volume: 136
  start-page: 1217
  year: 2012
  ident: 3031_CR18
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2012-0112-RA
– volume: 31
  start-page: 185
  year: 1987
  ident: 3031_CR70
  publication-title: Acta Cytol
– volume: 85
  start-page: 221
  year: 2019
  ident: 3031_CR71
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2018.11.005
– volume: 25
  start-page: 24
  year: 2018
  ident: 3031_CR57
  publication-title: Adv Anat Pathol
  doi: 10.1097/PAP.0000000000000180
– volume: 104
  start-page: 98
  year: 2017
  ident: 3031_CR34
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2016.12.017
– volume: 38
  start-page: 13
  year: 2014
  ident: 3031_CR54
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e3182a0218f
– volume: 12
  start-page: 367
  year: 1988
  ident: 3031_CR32
  publication-title: Ultrastruct Pathol
  doi: 10.3109/01913128809064207
– volume: 128
  start-page: 939
  year: 2020
  ident: 3031_CR14
  publication-title: Cancer Cytopathol
  doi: 10.1002/cncy.22326
– volume: 196
  start-page: 23
  year: 2015
  ident: 3031_CR53
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2015.01.043
– volume: 130
  start-page: 823
  year: 2006
  ident: 3031_CR12
  publication-title: Arch Pathol Lab Med
  doi: 10.1043/1543-2165(2006)130[823:EORCCM]2.0.CO;2
– volume: 36
  start-page: 1343
  year: 2018
  ident: 3031_CR42
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.76.6394
– volume: 35
  start-page: 1823
  year: 2011
  ident: 3031_CR17
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31822a2481
– volume: 30
  start-page: 1422
  year: 2017
  ident: 3031_CR68
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2017.61
– volume: 68
  start-page: 128
  year: 2018
  ident: 3031_CR41
  publication-title: Pathol Int
  doi: 10.1111/pin.12623
– volume: 41
  start-page: 425
  year: 2013
  ident: 3031_CR45
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.22852
– volume: 77
  start-page: 55
  year: 2020
  ident: 3031_CR9
  publication-title: Histopathology
  doi: 10.1111/his.14105
– volume: 41
  start-page: 1675
  year: 2017
  ident: 3031_CR13
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000935
– volume: 28
  start-page: 1043
  year: 2015
  ident: 3031_CR22
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2015.65
– volume: 144
  start-page: 446
  year: 2020
  ident: 3031_CR47
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2018-0457-OA
– volume: 25
  start-page: 260
  year: 2012
  ident: 3031_CR38
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2011.146
SSID ssj0021816
Score 2.5205123
SecondaryResourceType review_article
Snippet The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes—epithelioid, sarcomatoid, and biphasic. Recent genomic data has...
The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes-epithelioid, sarcomatoid, and biphasic. Recent genomic data has...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 59
SubjectTerms Annual review issues from Virchows Archiv
Biomarkers, Tumor - metabolism
Classification
Cyclin-Dependent Kinase Inhibitor p16 - metabolism
Diagnosis
Diagnosis, Differential
Diagnostic systems
Differential diagnosis
Effusion
Genomics
Humans
Immunohistochemistry
Medicine
Medicine & Public Health
Mesothelioma
Mesothelioma, Malignant - diagnosis
Mesothelioma, Malignant - metabolism
Mesothelioma, Malignant - pathology
Pathology
Pleural Neoplasms - diagnosis
Pleural Neoplasms - metabolism
Pleural Neoplasms - pathology
Review and Perspectives
Tumor Suppressor Proteins - metabolism
Tumors
Ubiquitin Thiolesterase - metabolism
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED90gvgifludUsEnNdg2TdM8iYhjCBMfHOyttGkCwtZOt_3_5rK0Q4aDvjVpwt01d7_cF8CtyGVRIMhRiqUkplySVESSJDQOFKdJkdpeh4P3pD-M30Zs5C7cZi6ssjkT7UFd1hLvyB-Nqg6TxNg34mn6TbBrFHpXXQuNbdjB0mUo1Xy0AlxGe1lfpYiZWTzkLmnGps5ZsEAwQMGIOQ0J_6uY1qzNNU-pVUC9A9h3lqP_vGT1IWyp6gh2B843fgx3H2OFNTT8iZphWtX4q57kvkTrGMOBLAf8xRQR_gkMe6-fL33iOiEQSTmbkzJKy1SrEs0rxaikZS50yLlOpQ7iQoR4pkWUslQXORZdMwMDoXQZMWUwbkFPoVPVlToHv5RaSAMaE1nmcZEYvCIEF1IbnlClVepB2JAhk65MOHarGGdtgWNLusyQLrOky7gH9-2c6bJIxsbR3Ya6mfthZtmKvR7ctK-NqKP_Iq9UvTBjYi44BpAGHpwtudIuR2lskA9lHjw0bFp9_P-9XGzeyyXsRVZE8OlCZ_6zUFfGCJkX11bSfgHl99Ne
  priority: 102
  providerName: ProQuest
Title Pleural mesothelioma classification update
URI https://link.springer.com/article/10.1007/s00428-021-03031-7
https://www.ncbi.nlm.nih.gov/pubmed/33475835
https://www.proquest.com/docview/2501660809
https://www.proquest.com/docview/2479710740
Volume 478
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED_cBuKL-G11jgo-qYW2aZrmcZPNoWwMcTCfSpsmIGzdcNv_7yVrKzIVhEIeek3L3TX5_biPANzwRKSpJjlS0sgJCBNOxH3hhCRwJSNhGpmzDgfDsD8OniZ0UhSFLcts9zIkaVbqqtjNwHtHpxSgYxLPYTVoUOTuOpFr7LcrmoV7lolQ8oDiKz1WlMr8PMf37WgLY27FR8220zuA_QIv2u2NgQ9hR-ZHsDsoIuLHcDuaSt05w57JpS6mmr7PZ4ktNCbWSUBG7_Z6oXn9CYx73deHvlOcf-AIwujKyfwoi5TMNKiSlAiSJVx5jKlIKDdIuadXMp8QGqk00a3WUNDlUmU-lchsU3IK9Xyey3OwM6G4QKoYiiwJ0hBZCueMC4WWIFLJyAKvVEMsiubg-oyKaVy1NTaqi1F1sVFdzCy4q55ZbFpj_CndLLUbF7_JMkb85YUhglZuwXV1Gx1cRy2SXM7XKBMwznTaqGvB2cYq1esICZDvEGrBfWmmr8l__5aL_4lfwp5vXEZfTaivPtbyCqHIKm1BjU1YCxrtXqcz1OPj23MXx053OHppGb_8BBnt1cQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LS8QwEB58gHoR39ZnBb2owbZpm-YgIj5YHyseFPZW2zQBYd1d3V3EP-VvdCbb7iKiN6G3pmk7M8nMl3kB7MpM5TmBHK2jhIVcKJbIQLGYh54WPM4T2-uwfhfXHsPrRtQYg88qF4bCKqs90W7URVvRGfkRqmo_jtG-kSedV0Zdo8i7WrXQGIjFjf54R8jWPb46R_7uBcHlxcNZjZVdBZjiIuqxIkiKxOiCTBUdccWLTBpfCJMo44W59Gl_CDiPEpNnVMAMB3pSmyKINOLFnOO84zCJitcjsCcaI4CH2tL6RmUY4c_6okzSsal6FpwwCojAZcV9Jr4rwh_W7Q_PrFV4l3MwW1qq7ulAtOZhTLcWYKpe-uIXYf--qalmh_uiu5TG1Xxuv2SuImucwo8sx91-h04UluDxX2i0DBOtdkuvglsoIxWC1FgVWZjHiI-kFFIZlAGujU4c8CsypKosS07dMZrpsKCyJV2KpEst6VLhwMHwmc6gKMefozcq6qblAu2mI3FyYGd4G5cW-Uuylm73cUwopKCAVc-BlQFXhq_jPESkxSMHDis2jSb__VvW_v6WbZiuPdRv09uru5t1mAmsuNC1ARO9t77eRAOol29ZqXPh6b_F_Atl-g-M
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swED-6FMJexrZ2nbd0c6F76SpqW7ZlPZSxLQlps4YwFsiba8sSDPLVJqH0X9tftzvFdhllfQv4zbJs351099N9ARzLTOU5gRyto4SFXCiWyECxmIeeFjzOE9vr8GoQ90bh5Tga78CfKheGwiqrPdFu1MVc0Rn5GapqP47RvpFnpgyLGLa7XxY3jDpIkae1aqexEZG-vr9D-LY8v2gjrz8FQbfz63uPlR0GmOIiWrEiSIrE6ILMFh1xxYtMGl8Ikyjjhbn0aa8IOI8Sk2dUzAwHelKbIog0Ysec47zPYFcQKmrA7rfOYPizhnuoO62nVIYR_rovypQdm7hnoQqj8AhcZNxn4l-1-MjWfeSnteqv-xJelHar-3UjaK9gR89eQ_Oq9MzvwclwoqmChzvVS0rqmvyeTzNXkW1OwUiW_-56QecL-zDaCpXeQGM2n-m34BbKSIWQNVZFFuYxoiUphVQGJYJroxMH_IoMqSqLlFOvjElal1e2pEuRdKklXSoc-Fw_s9iU6HhydKuiblou12X6IFwOHNW3caGR9ySb6fkax4RCCgpf9Rw42HClfh3nIeIuHjlwWrHpYfL_f8u7p7_lIzRRxNMfF4P-e3geWGmhqwWN1e1aH6I1tMo_lGLnwvW2Jf0vDaUVJw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pleural+mesothelioma+classification+update&rft.jtitle=Virchows+Archiv+%3A+an+international+journal+of+pathology&rft.au=Beasley%2C+Mary+Beth&rft.au=Galateau-Salle%2C+Francoise&rft.au=Dacic%2C+Sanja&rft.date=2021-01-01&rft.issn=0945-6317&rft.eissn=1432-2307&rft.volume=478&rft.issue=1&rft.spage=59&rft.epage=72&rft_id=info:doi/10.1007%2Fs00428-021-03031-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00428_021_03031_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0945-6317&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0945-6317&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0945-6317&client=summon